Search Login Register

8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine Summary

Description: orally active, small-molecule 5-hydroxytryptamine 2C agonist for the potential treatment of obesity and diabetes

Also Known As: APD 356; APD-356; APD356; AR-10A; lorcaserin

Networked: 100 relevant articles (16 outcomes, 27 trials/studies) for this Bio-Agent

Key Diseases for which 8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine is Relevant

  1. Weight Loss (Weight Reduction) : 8 outcomes 10 studies in 45 results
  2. Obesity : 7 outcomes 11 studies in 63 results
  3. Overweight : 2 outcomes 6 studies in 12 results
  4. Schizophrenia (Dementia Praecox) : 1 outcome in 1 result
  5. Central Nervous System Diseases (CNS Diseases) : 1 outcome in 1 result
Show All >>

Drugs Related to 8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine

  1. Phentermine (Adipex-P)
  2. topiramate (Topamax)
  3. 5-HT2C Serotonin Receptor
  4. orlistat (Xenical)
  5. Naltrexone (ReVia)
  6. Bupropion (Wellbutrin)
  7. Nicotine
  8. YM348
  9. 8- chloro- 2,3,4,5- tetrahydro- 1- methyl- 1H- 3- benzazepine
  10. Serotonin (5 Hydroxytryptamine)
Show All >>

Therapies Related to 8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine

  1. Drug Therapy (Chemotherapy)
  2. Therapeutics

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.